Table 1.
Study | Hereditary ataxia | Patients (n) | Cognitive deficits |
---|---|---|---|
Radvany et al., 1993 | SCA3 | 35 | Visual memory, visuospatial processing, colour discrimination |
Maruff et al., 1996 | SCA3 | 6 | Visual attention |
Zawacki et al., 2002 | SCA3 | 6 | Executive function |
Bürk et al., 2003 | SCA1, 2 and 3 | 36 | Verbal memory and executive deficits |
Kawai et al., 2004 | SCA3 | 16 | Verbal and visual memory, verbal fluency, visuospatial and constructional |
Klinke et al., 2010 | SCA1, 2, 3 and 6 | 36 | Frontal-attention and executive dysfunction |
Tedesco et al., 2011 | SCA1, SCA2, FRDA, AT and DVE | 24 | Language, visuospatial abilities, executive function, sequencing abilities and visuospatial memory |
Braga-Neto et al., 2012 | SCA3 | 38 | Executive and visuospatial functions |
Verhoeven et al., 2012 | ARSACS | 2 | Executive and motivation impairment |
Nieto et al., 2012 | FRDA | 36 | Executive, visuoconstrutive and visuoperceptive dysfunction and poor action naming |
Roeske et al., 2013 | SCA3 | 11 | Verbal learning, verbal and nonverbal memory |
Lopes et al., 2013 | SCA3 | 32 | Episodic and working memory |
Fancellu et al., 2013 | SCA1 and 2 | 42 | Executive functions and visuospatial and visuoperceptive function |
SCA = spinocerebellar ataxia; ARSACS = autosomal recessive spastic ataxia of Charlevoix-Saguenay; FRDA = Friedreich’s ataxia; AOA2 = ataxia with oculomotor apraxia type 2; AT = ataxia-telangiectasia; DVE = deficiency of vitamin E.